Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5-Reference-Cited by-同舟云学术

Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5

Published:2023-05 Issue: Volume:39 Page:100894
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Jeon Hye-Min,Oh Young Taek,Shin Yong Jae,Chang Nakho,Kim Donggeun,Woo Donghun,Yeup Yoon^ORCID,Joo Kyeung Min^ORCID,Jo Heejin,Yang Heekyoung,Lee Jin-Ku,Kang Wonyoung,Sa Jason,Lee Won Jun,Hale James,Lathia Justin D.,Purow Benjamin,Park Myung Jin^ORCID,Park Jong Bae,Nam Do-Hyun,Lee Jeongwu

Publisher

Elsevier BV

Subject

Cancer Research

Reference60 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N. Engl. J. Med.,2005

2. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

3. Cancer stem cells in glioblastoma;Lathia;Genes Dev.,2015

4. Glioblastoma stem cells: driving resilience through chaos;Prager;Trends Cancer,2020

5. The physiology, signaling, and pharmacology of dopamine receptors;Beaulieu;Pharmacol. Rev.,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating glioblastoma complexity: the interplay of neurotransmitters and chromatin;Molecular Biology Reports;2024-08-17

2. Role of Scaffold Proteins in the Heterogeneity of Glioblastoma;2024-07-29

3. Iloperidone and Temozolomide Synergistically Inhibit Growth, Migration and Enhance Apoptosis in Glioblastoma Cells;Biomedicines;2024-05-21

4. Imipridones and Dopamine Receptor Antagonism in the Therapeutic Management of Gliomas;Advances in Oncology;2024-05

5. Metabolic vulnerability of cancer stem cells and their niche;Frontiers in Pharmacology;2024-04-10